期刊文献+

快速膜乳化法制备尺寸均一及结构可控聚苯乙烯微粒 被引量:3

Preparation of Uniform and Heterogeneous Structure Polystyrene Particles by Premix Membrane Emulsification
原文传递
导出
摘要 以苯乙烯为单体、二乙烯基苯为交联剂,采用快速膜乳化法制备了聚苯乙烯微粒,对其粒径分布、制备重复性、颗粒结构进行了表征,并考察了致孔剂种类及用量对不同粒径颗粒形态结构的影响规律.结果表明,聚苯乙烯颗粒粒径与所用膜孔径呈线性关系,最佳乳化压力与膜孔径呈反函数关系.优化工艺条件下所制颗粒粒径为1~6m,粒径分布系数均小于0.8,批次相对标准偏差低于3%.体积效应对小粒径颗粒的成型结构影响较大;粒径越小,颗粒成型时致孔剂与聚合物间的相分离程度越低,颗粒粒径小于2m时液体石蜡无法形成完整颗粒,颗粒粒径大于2m时十六烷用量在60%(ω)以下才能形成大孔结构. Uniform polystyrene (PST) particles with controlled heterogeneous structure were synthesized by premix membrane emulsification method, the effects of the emulsification pressure and cycles, pore size of the membrane used, and porogen on the PST particle size and uniformity were studied. The results indicate that the membrane pore size has linear relation with the average diameter of PST particles and is in inverse proportion to the optimum emulsification pressure. The prepared PST particle sizes can be controlled in 1-6 μm with the size distribution index Span of 0.8, and the relative standard deviation of reproducibility within 3%. Furthermore, the degree of phase separation between polymers and porogen decreases with decreasing of the particle size. Liquid paraffin is unsuitable as the porous medium for the particle size smaller than 2 μm, hexadecane can be used as macroporous medium but with the dosage of under 60% when the particle size is larger than 2 μm.
出处 《过程工程学报》 CAS CSCD 北大核心 2013年第2期275-280,共6页 The Chinese Journal of Process Engineering
基金 北京市自然科学基金资助项目(编号:3112023)
关键词 快速膜乳化 粒径均一 结构可控 致孔剂 premix membrane emulsification uniform structure controlling porogen
  • 相关文献

参考文献27

  • 1Bercea M, Ecaterina S D. New Trends in Nonionic (Co)polymers and Hybrids [M]. New York: Nova Science Pub., 2006. 123-130, 134-137.
  • 2Wang Y, Gao S, Ye W H, et al. Co-delivery of Drugs and DNA from Cationic Core-Shell Nanoparticles Self-assembled from a Biodegradable Copolymer [J]. Nat. Mater., 2006, 5(10): 791-796.
  • 3Yue H, Wei W, Fan B, et al. The Orchestration of Cellular and Humoral Responses is Facilitated by Divergent Intracellular Antigen Trafficking in Nanoparticle-based Therapeutic Vaccine [J]. Pharm.Res., 2012, 65(2): 189-197.
  • 4Kim J A, Aberg C, Salvati A, et al. Role of Cell Cycle on the Cellular Uptake and Dilution of Nanoparticles in a Cell Population [J]. Nat. Nanotechnol., 2011, 7(1): 62-68.
  • 5Lunov O, Syrovets T, Loos C, et al. Differential Uptake of Functionalized Polystyrene Nanoparticles by Human Macrophages and a Monocytic Cell Line [J]. ACS Nano., 2011, 5(3): 1657-1669.
  • 6Diez S, Tros de Ilarduya C. Versatility of Biodegradable Poly(D, L-lactic-co-glycolic acid) Microspheres for Plasmid DNA Delivery [J]. Eur. J. Pharm. Biopharm., 2006, 63(2): 188-197.
  • 7Diez S, Migu61iz I, Tros de Ilarduya C. Targeted Cationic Poly(D, L-lactic-co-glycolic acid) Nanoparticles for Gene Delivery to Cultured Cells [Jl. Cellul. Mol. Biol. Lett 2009 14(2): 347-362.
  • 8朱雯,黄芳婷,董观秀,张明.无皂乳液聚合法制备单分散聚苯乙烯微球[J].功能材料,2012,43(6):775-778. 被引量:18
  • 9Okubo M, Ise E, Yamashita T. Synthesis of Greater than 10-mm-sized, Monodispersed Polymer Particles by One-step Seeded Polymerization for Highly Monomer-swollen Polymer Particles Prepared Utilizing the Dynamic Swelling Method [J]. J. Appl. Polym. Sei., 1999, 74(2): 278-285.
  • 10Omi S, Senba T, Nagai M, et al. Morphology Development of 10 :tm Scale Polymer Particles Prepared by SPG Emulsification and Suspension Polymerization [J]. J. Appl. Polym. Sci., 2001, 79(12): 2200-2220.

二级参考文献62

共引文献44

同被引文献48

  • 1路世鹏,王玉蓉.均匀设计和正交设计法优选吴茱萸提取工艺的研究[J].北京中医药大学学报,2004,27(5):66-70. 被引量:7
  • 2古永红,王连艳,谭天伟,马光辉.尺寸均一的壳聚糖微球的制备及其作为胰岛素控释载体的研究[J].生物工程学报,2006,22(1):150-155. 被引量:21
  • 3翟荣玲,徐怀英,王友令,秦卓明,姜世金,贾强,李莉,欧阳文军.新城疫壳聚糖微球疫苗免疫效果的研究[J].微生物学报,2007,47(4):692-696. 被引量:8
  • 4Sirkha V R, Trehan A. Biodegradable Microspheres for Protein Delivery [J]. J. Controlled Release, 2003, 90(3): 261-280.
  • 5Sarmento B, Ribeiro A, Veiga F, et al. Alginate/Chitosan Nanoparticles Are Effective for Oral Insulin Delivery [J]. Pharm. Res., 2007, 24(12): 2198-2206.
  • 6Herrero-Vanrell R, Refojo M F. Biodegradable Microspkeres for Vitreoretinal Drug Delivery [J]. Advance Drug Delivery Reviews, 2001, 52(1): 5-16.
  • 7Krauland A H, Guggi D, Bernkop-Schnurch A. Thiolated Chitosan Microparticles: A Vehicle for Nasal Peptide Drug Delivery [J]. Int. J. Pharm., 2006, 307(2): 270-277.
  • 8Akbuga J, Ozbas-Turan S, Erdogan N. Plasmid-DNA Loaded Chitosan Microspheres for in vitro IL-2 Expression [J]. Eur, J. Pharnx Biopharm., 2004, 58(3): 501-507.
  • 9Park J M, Lee S Y, Lee G H, et al. Design and Characterisation of Doxorubicin-releasing Chitosan Microspheres for Anti-cancer Chemoembolisation [J]. J. Microencapsulation, 2012, 29(7): 695-705.
  • 10Kumbar S G; Soppimath K S, Aminabhavi T M. Synthesis and Characterization of Polyacrylamide-grafted Chitosan Hydrogel Mierospheres for the Controlled Release of Indomethaein [J]. J. Appl. Polym. Sci., 2003, 87(9): 1525-1536.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部